NAIROBI: Kenyans will soon benefit from cheaper drugs to treat chronic diseases after a pharmaceutical company announced it would launch its products next month.
The portfolio called Norvatis Access, will include 15 medicines meant to treat chronic illnesses such as cardiovascular diseases, diabetes, respiratory illnesses and breast cancer. A single treatment case will cost Sh105 a month.